Literature DB >> 15834121

Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease.

Elaine W Raines1, Nicola Ferri.   

Abstract

The cellular and extracellular matrix accumulations that comprise the lesions of atherosclerosis are driven by local release of cytokines at sites of predilection for lesion formation, and by the specific attraction and activation of cells expressing receptors for these cytokines. Although cytokines were originally characterized for their potent effects on immune and inflammatory cells, they also promote endothelial cell dysfunction and alter smooth muscle cell (SMC) phenotype and function, which can contribute to or retard vascular pathologies. This review summarizes in vivo studies that have characterized endothelial- and smooth muscle-specific effects of altering cytokine signaling in vascular disease. Although multiple reports have identified cytokines as pivotal players in endothelial and SMC responses in vascular disease, they also have highlighted the need to delineate the critical genes and specific cellular functions regulated by individual cytokine signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834121     DOI: 10.1194/jlr.R500004-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  63 in total

1.  Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.

Authors:  Anthony A Cuneo; David Herrick; Michael V Autieri
Journal:  J Mol Cell Cardiol       Date:  2010-05-06       Impact factor: 5.000

2.  FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells.

Authors:  Min Zhu; Qing-Jun Zhang; Lin Wang; Hao Li; Zhi-Ping Liu
Journal:  Atherosclerosis       Date:  2011-10-02       Impact factor: 5.162

Review 3.  Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis.

Authors:  Anthony Wayne Orr; Nicole E Hastings; Brett R Blackman; Brian R Wamhoff
Journal:  J Vasc Res       Date:  2009-10-22       Impact factor: 1.934

Review 4.  A systems biology approach to understanding atherosclerosis.

Authors:  Stephen A Ramsey; Elizabeth S Gold; Alan Aderem
Journal:  EMBO Mol Med       Date:  2010-03       Impact factor: 12.137

5.  C1q and TNF related protein 1 regulates expression of inflammatory genes in vascular smooth muscle cells.

Authors:  Dough Kim; Seung-Yoon Park
Journal:  Genes Genomics       Date:  2018-11-24       Impact factor: 1.839

6.  Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.

Authors:  Chang Hyun Byon; Tieyan Han; Judy Wu; Simon T Hui
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

7.  Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell pathophysiology and development of intimal hyperplasia.

Authors:  Ying Tian; Laura J Sommerville; Anthony Cuneo; Sheri E Kelemen; Michael V Autieri
Journal:  Am J Pathol       Date:  2008-07-31       Impact factor: 4.307

Review 8.  Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury.

Authors:  Anthony A Cuneo; Michael V Autieri
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

9.  TNF-alpha stimulates the ACAT1 expression in differentiating monocytes to promote the CE-laden cell formation.

Authors:  Lei Lei; Ying Xiong; Jia Chen; Jin-Bo Yang; Yi Wang; Xin-Ying Yang; Catherine C Y Chang; Bao-Liang Song; Ta-Yuan Chang; Bo-Liang Li
Journal:  J Lipid Res       Date:  2009-02-02       Impact factor: 5.922

Review 10.  IGF-1, oxidative stress and atheroprotection.

Authors:  Yusuke Higashi; Sergiy Sukhanov; Asif Anwar; Shaw-Yung Shai; Patrice Delafontaine
Journal:  Trends Endocrinol Metab       Date:  2010-01-12       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.